Using AMCA to Label the Fetal Cell Antigen in Fetal Erythroblasts Circumvents Heme Autofluorescence, Enhances cFISH Efficiency and Improves Specificity of Fetal Cell Identification

Author(s):  
M. Choolani ◽  
H. O�Donnell ◽  
C. Campagnoli ◽  
S. Kumar ◽  
I. Roberts ◽  
...  
1995 ◽  
Vol 15 (3) ◽  
pp. 261-268 ◽  
Author(s):  
Ossie Geifman-Holtzman ◽  
Eliezer J. Holtzman ◽  
Theresa J. Vadnais ◽  
Vincent E. Phillips ◽  
Eleanor L. Capeless ◽  
...  

Author(s):  
Priscilla Song

Thousands of people from more than eighty countries have traveled to China since 2001 to undergo fetal cell transplantation. Galvanized by the potential of stem and fetal cells to regenerate damaged neurons and restore lost bodily functions, people grappling with paralysis and neurodegenerative disorders have ignored the warnings of doctors and scientists back home in order to stake their futures on a Chinese experiment. This book looks at why and how these individuals have entrusted their lives to Chinese neurosurgeons operating at the forefront of experimental medicine, in a world where technologies and risks move faster than laws can keep pace. The book shows how cutting-edge medicine is not just about the latest advances in biomedical science but also encompasses transformations in online patient activism, surgical intervention, and borderline experiments in health care bureaucracy. The book opens up important theoretical and methodological horizons in the anthropology of science, technology, and medicine. It illuminates how poignant journeys in search of fetal cell cures become tangled in complex webs of digital mediation, the entrepreneurial logics of postsocialist medicine, and fraught debates about the ethics of clinical experimentation. Using innovative methods to track the border-crossing quests of Chinese clinicians and their patients from around the world, the book maps the transnational life of fetal cell therapies.


Sign in / Sign up

Export Citation Format

Share Document